期刊文献+

基于铁蛋白等血清学指标的早期NAFLD诊断模型的建立与验证

Establishment and validation of an early NAFLD diagnosis model based on serum markers such as ferritin
下载PDF
导出
摘要 目的建立便于临床应用且诊断效能高的无创预测模型辅助诊断早期非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)。方法收集2019年6月1日至2022年6月30日在浙江省人民医院确诊的NAFLD患者和健康体检者的临床资料,随机分为训练集(n=184)和验证集(n=48)。在训练集中通过多因素Logistic回归分析方法,筛选早期NAFLD诊断的血清学指标,建立NAFLD的早期无创诊断模型。使用训练集构建诊断模型,并在验证集中进行外部验证。将诊断结果与实际情况进行对比分析,证明所建模型具有一定的可靠性和有效性。最后绘制受试者操作特征曲线,并计算曲线下面积,以此评估预测模型的准确程度。结果根据二元Logistic回归分析结果,最终纳入铁蛋白等4个预测因子,建立诊断模型,经验证集数据证实诊断准确性较好。结论基于铁蛋白等血清学指标初步建立关于早期NAFLD诊断预测模型且诊断效能良好,可用于NAFLD的早期诊断。 Objective To establish a non-invasive prediction model which is convenient for clinical application and improves diagnostic efficiency to assist the diagnosis early stage of non-alcoholic fatty liver disease(NAFLD).Methods Clinical data of patients with NAFLD and some healthy patients diagnosed by imaging in Zhejiang Provincial People’s Hospital from June 1,2019 to June 30,2022 were collected and randomly divided into a training set(n=184)and a validation set(n=48).In the training set,the serological indexes of early diagnosis of NAFLD were screened by multivariate Logistic regression analysis,and the early noninvasive diagnosis model of NAFLD was established.The diagnostic model was builted through the training set and externally verified in the verification set.To assess the prediction model's accuracy,the receiver operating characteristic curve was built and the area under the curve was constructed.Results According to the results of binary Logistic regression analysis,ferritin and other four predictors were finally included,and the diagnostic model was established according to the above factors.The empirical data confirmed that the diagnostic accuracy was good.Conclusion The prediction model of early NAFLD diagnosis was established based on serological indexes such as ferritin,which has good diagnostic efficacy and can be used for early diagnosis of NAFLD.
作者 吴韵怡 敬强安 杜璟 童向民 WU Yunyi;JING Qiang’an;DU Jing;TONG Xiangmin(The Second Clinical School,Zhejiang Chinese Medical University,Hangzhou 310053,Zhejiang,China;Institute of Clinical Medicine,Zhejiang Provincial People’s Hospital,People’s Hospital of Hangzhou Medical College,Hangzhou 310014,Zhejiang,China)
出处 《中国现代医生》 2024年第6期36-39,共4页 China Modern Doctor
基金 2023年浙江省医药卫生科技计划项目(2023RC004)。
关键词 非酒精性脂肪性肝病 诊断模型 铁蛋白 Non-alcoholic fatty liver disease Diagnosis model Ferritin
  • 相关文献

参考文献7

二级参考文献82

  • 1中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):43-48. 被引量:469
  • 2颜红梅,高鑫,刘蒙,顾迁,张斌,李湘,高键,赵耐青.非酒精性脂肪肝与代谢综合征关系的研究[J].中国糖尿病杂志,2006,14(5):326-328. 被引量:74
  • 3Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander- Tetri BA, Chalasani N, Sanyal AJ, Nelson JE. Serum fer- ritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2012; 55:77-85.
  • 4Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50:1844-1850.
  • 5Day CP. From fat to inflammation. Gastroenterology 2006; 130:207-210.
  • 6Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, Rizzetto M. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterolo/2002; 123:134-140.
  • 7Musso G, Gambino R, Cassader M, Pagano G. Meta- analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43:617-649.
  • 8Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40:1387-1395.
  • 9Bellentani S, Saccoccio G, Masutti F, Croc LS, Brandi G, Sasso F, Cristanini G, Tiribelli C. Prevalence of and risk fac- tors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132:112-117.
  • 10Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonas- cia J, Unalp A, Van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010;362:1675-1685.

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部